Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease

Urology

Volumn 51, Issue 3, 1998, Pages 449-454

  D'Amico, Anthony V ^a   Schnall, Mitchell ^a   Whittington, Richard ^a   Malkowicz, S Bruce ^a   Schultz, Delray ^a   Tomaszewski, John E ^a   Wein, Alan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

DISEASE-FREE SURVIVAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RECTUM; SENSITIVITY AND SPECIFICITY;

EID: 0032030480     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00630-4     Document Type: Article

References (20)

1. Platt JF, Bree RL, Schwab RE. The accuracy of CT in the staging of prostatic carcinoma. Am J Radiol. 149:1987;315-318.
2. Rifkin MD, Zerhouni A, Gatsonis CA, Quint LE, Paushier DM, Epstein JI, Hamper U, Walsh PC, McNeil BJ. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med. 323:1990;621-626.
3. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. Use of the endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol. 150:1993;391-395.
4. Krebs TL, Silverman JM. Clinical utility of endorectal surface coil imaging of the prostate gland. Radiol Sci North Am. 275:1992;. abstract 1006.
5. Tempany CM, Zhou X, Zerhouni EA, Rifkin MD, Quint LE, Piccoli LW, Ellis JH, McNeil BJ. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology. 192:1994;47-54.
6. Quinn SF, Franzini DA, Demlow TA, Rosenkrantz DR, Kim J, Hanna RM, Szumowski J. MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. Radiology. 190:1994;323-327.
7. Perrotti M, Kaufman RP Jr, Jennings TA, Thaler HT, Soloway SM, Rifkin MD, Fisher HAG. Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol. 156:1996;106-109.
8. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszewski JE, Wein A. A multivariable analysis evaluating the role of the percent positive biopsies and endorectal coil MRI in predicting extraprostatic disease and time to postoperative PSA failure in intermediate risk prostate cancer patients. Cancer. 2:1996;343-350.
9. D'Amico AV. Letter to the Editor Re: Endorectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? Perrotti M, Kaufman RP Jr, Jennings TA, Thaler HT, Soloway SM, Rifkin MD, Fisher HAG. J Urol. 156:1996;106-109.
10. D'Amico AV. Letter to the Editor Re: Endorectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? Perrotti M, Kaufman RP Jr, Jennings TA, Thaler HT, Soloway SM, Rifkin MD, Fisher HAG. J Urol. 157:1997;1371-1372.
11. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer. 71:1993;3582-3593.
12. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol. 152:1994;1831-1836. (5Pt2).
13. Gleason DF. Histologic grading and staging of prostatic carcinoma. Tannenbaum M. Urologic Pathology. 1977;171-187 Lea & Febiger, Philadelphia.
14. Oesterling JE, Jacobsen SJ, Klee GG, Pettersson K, Pironen T, Abrahamsson P, Stenman U, Dowell B, Lovgren T, Lilja H. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol. 154:1995;1090-1095.
15. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. 4th ed. American Joint Committee on Cancer, Manual for Staging Cancer. 1992;Lippincott, Philadelphia.
16. Schnall MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY. Prostate: MR imaging with an endorectal surface coil. Radiology. 172:1989;570-5741.
17. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-467.
18. Partin AW, Pearson JD, Landia PK, Carter HB, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Evaluation of the prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 43:1994;649-659.
19. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Wein A. Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial. J Clin Oncol. 15:1997;1465-1469.
20. Bolla M, Gonsalez D, Warde P, Dubois JB, Mirimanoff R, Storme G, Bernier J, Kuten A, Sternberg, Gil T, Collette L, Pierant M. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300.